Confluent Medical Technologies, Scottsdale, AZ, announced that Dean Schauer has been appointed Chairman of the Board, effective September 9, 2024.
Schauer, who has served as the company’s CEO for over a decade, will now take on the additional role of Chairman while continuing his responsibilities as CEO and President. Schauer expressed his gratitude for the trust placed in him by investors and employees, stating, “I am honored to guide the company into the next phase as we continue to deliver value to our partners and the patients they serve.”
Under Schauer’s leadership, Confluent has seen significant growth, with revenue more than quadrupling. His appointment aligns with the company’s strategic goals to enhance its materials science capabilities and expand customer partnerships. Earlier this year, Confluent welcomed Sandy Stojkovski and Brian Yoor to the board, further strengthening its leadership team. TPG, a global asset management firm, invested in Confluent in 2022, underscoring confidence in Schauer’s leadership.
